Upgradeable Firmware: The Cochlear™ Nucleus® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates.

Opportunities include AI-enabled connected implants, broader bilateral and adult indications, earlier pediatric treatment, remote care through ENT clinics, outpatient procedures, and expanded access ...

Cochlear reported FY26 sales of $2.3 billion, up 2% in constant currency, underscoring modest top‑line growth despite macro and pricing pressures. The second half showed better traction with revenue ...

Researchers have developed a non-invasive method for mapping the human auditory pathway, which could potentially be used as a tool to help clinicians decide the best surgical strategy for patients ...

One of the most significant hurdles to providing gene therapies for hearing loss is access to the inner ear. Our ears are intricate and feature complex structures that make getting treatment into the ...

Researchers at the Pasteur Institute in France have conducted an in-depth genomic study of mouse cochlea to create a comprehensive transcriptomic atlas of the auditory organ at a molecular level. In ...

Bone-anchored hearing aids (BAHAs) and cochlear implants are devices that can improve the quality of a person’s hearing. They work in different ways, and each has specific advantages and disadvantages ...

These are three ASX healthcare shares I would be happy to own for years. The post Why I'd buy CSL, Cochlear, and Pro Medicus shares appeared first on The Motley Fool Australia.